Literature DB >> 29023336

Correlation between functional imaging markers derived from diffusion-weighted MRI and 18F-FDG PET/CT in esophageal cancer.

Lucas Goense1,2, Sophie E Heethuis1, Peter S N van Rossum1, Francine E M Voncken3, Jan J W Lagendijk1, Marnix G E H Lam4, Chris H Terhaard1, Richard van Hillegersberg2, Jelle P Ruurda2, Stella Mook1, Astrid L H M W van Lier1, Steven H Lin5, Gert J Meijer1.   

Abstract

OBJECTIVE: Both the apparent diffusion coefficient (ADC) acquired by diffusion-weighted magnetic resonance imaging (DW-MRI) and the standardized uptake value (SUV), acquired by F-fluorodeoxyglucose positron emission tomography/computed tomography (F-FDG PET/CT), are well-established functional parameters in cancer imaging. Currently, it is unclear whether these two markers provide complementary prognostic and predictive information in esophageal cancer. The aim of this study was to evaluate the correlation between ADC and SUV in patients with esophageal cancer.
MATERIALS AND METHODS: This prospective study included 76 patients with histologically proven esophageal cancer who underwent both DW-MRI and F-FDG PET/CT examinations before treatment. The minimum and mean ADC values (ADCmin and ADCmean) of the primary tumor were assessed on MRI. Similarly, the glucose metabolism was evaluated by the maximum and mean SUV (SUVmax and SUVmean) in the same lesions on F-FDG PET/CT images. Spearman's rank correlation coefficients were used to assess the correlation between tumor ADC and SUV values.
RESULTS: The tumor ADC and SUV values as measures of cell density and glucose metabolism, respectively, showed negligible nonsignificant correlations (ADCmin vs. SUVmax: r=-0.087, P=0.457; ADCmin vs. SUVmean: r=-0.105, P=0.369; ADCmean vs. SUVmax: r=-0.099, P=0.349; ADCmean vs. SUVmean: r=-0.111, P=0.340). No differences in tumor ADC and SUV values were observed between the different histologic tumor types, stages, and differentiation grades.
CONCLUSION: This study indicates that tumor cellularity derived from DW-MRI and tumor metabolism measured by F-FDG PET/CT are independent cellular phenomena in newly diagnosed esophageal cancer. Therefore, tumor ADC and SUV values may play complementary roles as imaging markers in the prediction of survival and evaluation of response to treatment in esophageal cancer.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29023336     DOI: 10.1097/MNM.0000000000000771

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  9 in total

1.  Imaging characteristics of esophageal cancer in multi-slice spiral CT and barium meal radiography and their early diagnostic value.

Authors:  Jiafu Wang; Liang Tang; Lin Lin; Yanyan Li; Jin Li; Wenbo Ma
Journal:  J Gastrointest Oncol       Date:  2022-02

2.  Quantitative 3D Assessment of 68Ga-DOTATOC PET/MRI with Diffusion-Weighted Imaging to Assess Imaging Markers for Gastroenteropancreatic Neuroendocrine Tumors: Preliminary Results.

Authors:  Lisa C Adams; Keno K Bressem; Julia Brangsch; Carolin Reimann; Kristin Nowak; Winfried Brenner; Marcus R Makowski
Journal:  J Nucl Med       Date:  2019-12-20       Impact factor: 10.057

3.  Cervical Cancer: Associations between Metabolic Parameters and Whole Lesion Histogram Analysis Derived from Simultaneous 18F-FDG-PET/MRI.

Authors:  Hans-Jonas Meyer; Sandra Purz; Osama Sabri; Alexey Surov
Journal:  Contrast Media Mol Imaging       Date:  2018-07-30       Impact factor: 3.161

4.  Exploratory radiomic features from integrated 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging are associated with contemporaneous metastases in oesophageal/gastroesophageal cancer.

Authors:  Serena Baiocco; Bert-Ram Sah; Andrew Mallia; Christian Kelly-Morland; Radhouene Neji; J James Stirling; Sami Jeljeli; Alessandro Bevilacqua; Gary J R Cook; Vicky Goh
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-03-27       Impact factor: 9.236

5.  Geometrical Comparison and Quantitative Evaluation of 18F-FDG PET/CT- and DW-MRI-Based Target Delineation Before and During Radiotherapy for Esophageal Squamous Carcinoma.

Authors:  Huimin Li; Jianbin Li; Fengxiang Li; Yingjie Zhang; Yankang Li; Yanluan Guo; Liang Xu
Journal:  Front Oncol       Date:  2021-12-22       Impact factor: 6.244

Review 6.  A decade of multi-modality PET and MR imaging in abdominal oncology.

Authors:  Lisa A Min; Francesca Castagnoli; Wouter V Vogel; Jisk P Vellenga; Joost J M van Griethuysen; Max J Lahaye; Monique Maas; Regina G H Beets Tan; Doenja M J Lambregts
Journal:  Br J Radiol       Date:  2021-08-13       Impact factor: 3.629

7.  Correlation between microvessel density (MVD) and multi-spiral CT (MSCT) perfusion parameters of esophageal cancer lesions and the diagnostic value of combined CtBP2 and P16INK4A.

Authors:  Qinghua Li; Dong Cui; Yu Feng; Yanfei He; Zheng Shi; Rui Yang
Journal:  J Gastrointest Oncol       Date:  2021-06

8.  Optimal timing for prediction of pathologic complete response to neoadjuvant chemoradiotherapy with diffusion-weighted MRI in patients with esophageal cancer.

Authors:  Alicia S Borggreve; Sophie E Heethuis; Mick R Boekhoff; Lucas Goense; Peter S N van Rossum; Lodewijk A A Brosens; Astrid L H M W van Lier; Richard van Hillegersberg; Jan J W Lagendijk; Stella Mook; Jelle P Ruurda; Gert J Meijer
Journal:  Eur Radiol       Date:  2019-12-10       Impact factor: 5.315

9.  The diagnostic significance of 64-slice spiral CT combined with serological CA19-9, Bcl-2, CYFRA21-1 detection in thoracic esophageal carcinoma.

Authors:  Junfei Hao; Wei Liu; Chunyan Zhao; Taiyu Xia
Journal:  Transl Cancer Res       Date:  2021-12       Impact factor: 1.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.